Improvement of RNA Aptamer Activity against Myasthenic Autoantibodies by Extended Sequence Selection

This publication has 23 references indexed in Scilit:

• Potent 2′-amino-, and 2′-fluoro-2′- deoxyribonucleotide RNA inhibitors of keratinocyte growth factor
  Nature Biotechnology, 1997
• Isolation of a nuclease-resistant decoy RNA that can protect human acetylcholine receptors from myasthenic antibodies
  Nature Biotechnology, 1997
• Isolation of a nuclease-resistant decoy RNA that selectively blocks autoantibody binding to insulin receptors on human lymphocytes.
  The Journal of Experimental Medicine, 1996
• DIVERSITY OF OLIGONUCLEOTIDE FUNCTIONS
  Annual Review of Biochemistry, 1995
• Myasthenia Gravis
  New England Journal of Medicine, 1994
• Bacterial expression of a single‐chain Fv fragment which efficiently protects the acetylcholine receptor against antigenic modulation caused by myasthenic antibodies
  European Journal of Immunology, 1993
• Kinetic Characterization of Ribonuclease-Resistant 2′-Modified Hammerhead Ribozymes
  Science, 1991
• In vitro selection of RNA molecules that bind specific ligands
  Nature, 1990
• Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA Polymerase
  Science, 1990
• Antibody Heterogeneity and Specificity in Myasthenia Gravis^a
  Annals of the New York Academy of Sciences, 1987